Molina Healthcare, Inc (NYSE:MOH – Get Free Report) CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Molina Healthcare Trading Down 1.1%
Shares of MOH stock traded down $2.02 during mid-day trading on Friday, hitting $184.78. 878,989 shares of the company’s stock were exchanged, compared to its average volume of 1,682,156. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $327.68. The stock has a 50-day simple moving average of $156.26 and a two-hundred day simple moving average of $158.72. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The stock has a market cap of $9.63 billion, a price-to-earnings ratio of 54.67 and a beta of 0.85.
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. During the same quarter last year, the firm earned $6.08 earnings per share. The business’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
MOH has been the topic of a number of research analyst reports. Zacks Research upgraded Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Cantor Fitzgerald lifted their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday. Barclays lifted their target price on Molina Healthcare from $133.00 to $161.00 and gave the company an “underweight” rating in a report on Friday, April 24th. UBS Group lifted their target price on Molina Healthcare from $151.00 to $180.00 and gave the company a “neutral” rating in a report on Friday, April 24th. Finally, Robert W. Baird lifted their target price on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a report on Monday. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $174.53.
Get Our Latest Research Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
